Dünya
Ecza Deposu Medical
ABS Effect Mechanism
Ankaferd BloodStopper, a hemorrhage stopping preparation, forms a network inside plazma or serum fast (in a matter of split seconds). General haemostatic and biochemical tests have shown that the mentioned network is formed via the interaction between Ankaferd BloodStopper and proteins in blood; but primarily via the products interaction with fibrinogen. The tests also show that red spheres provide vital aggregation. At this stage, the process of holding hemorrahgage at a certain level to allow tissue repair/restoration is primarily related with protein erythrocyte interaction. Blood cells too take their part in the network. Independent of the physiological haemostatic process tissue factor related to blood coagulation, Ankaferd BloodStopper, developes without effecting this system. Therefore Ankaferd BloodStopper is not only effective on patients with normal haemostatic values, but also on those who are primary and secondary homestaz defective. Ankaferd BloodStopper can be employed as an aide product in clinique pocedures for stopping intensive dental hemorrhaging, including mucousal fissures. Ankaferd BloodStopper must not be injected into vein or blood circulation system.0216-4612648-49
Gastric Bleeding
Ankaferd Blood Stopper application for Gastric Bleeding
Subcutaneous bleeding model
Ankaferd Blood Stopper In Vivo Experiment
Venous bleeding model
Ankaferd Blood Stopper In Vivo Experiment
Artery bleeding model
Ankaferd Blood Stopper In Vivo Experiment
ABS affect on blood under microscope
Ankaferd Blood Stopper In Vitro Experiment
Bleeding spleen damage model
Ankaferd Blood Stopper In Vivo Experiment